Source: Hematological Oncology. Unidade: FMRP
Subjects: HEMATOLOGIA, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Juliana Cordeiro et al. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hon.2608. Acesso em: 23 ago. 2024. , 2019APA
Sousa, J. C., Ito, M. N., Costa, M. B., Farias, I. R., Borges, D. P., Oliveira, R. T., et al. (2019). Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hon.2608NLM
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1002/hon.2608Vancouver
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1002/hon.2608